Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.

Authors :: Herling M
Dearden C
Zaja F
El-Sharkawi D
Ding W
Bellido M
Khot A
Tick L
Jacobsen E
Eyre TA
Roos-Weil D
Kadia T
Lucchini E
Pflug N
Davids MS
Pena G
Mukherjee N
Badawi M
Vizkelety T
Staber PB
Source :: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 842-845.
Publication Year :: 2024

Subjects :: Humans
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Leukemia, Prolymphocytic, T-Cell
Adenine analogs & derivatives
Piperidines
Sulfonamides

Full Text Access

Tools